HCPCS Level IIdrugActive
J9275
Inj cosibelimab-ipdl, 2 mg
BETOS: O1D
Effective: 2025-07-01
Description
Injection, cosibelimab-ipdl, 2 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Unloxcyt
Manufacturer
Checkpoint Therapeutics Inc
HCPCS Dosage
2 MG
Billing Units
150.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.